Evidence map›Paper›PMID 25061304›Full record

ArticleNeuropsychiatric disease and treatment2014

The predictive value of somatic and cognitive depressive symptoms for cytokine changes in patients with major depression.

Katharina Dannehl, Winfried Rief, Markus J Schwarz, Annika Hennings, Sabine Riemer, Verena Selberdinger, Theresa Stapf, Frank Euteneuer

Abstract read
In one paragraph

Article in Neuropsychiatric disease and treatment, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Inflammation and the dimensions of depression: A review.Frontiers in neuroendocrinology · 2020
    Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Cytokines and depression in cancer patients and caregivers.Neuropsychiatric disease and treatment · 2017
    Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Katharina DannehlDivision of Clinical Psychology and Psychotherapy, Philipps Universität Marburg, Marburg, Germany.
Winfried RiefDivision of Clinical Psychology and Psychotherapy, Philipps Universität Marburg, Marburg, Germany.
Markus J SchwarzInstitute for Laboratory Medicine, Ludwig-Maximilian Universität, Munich, Germany.
Annika HenningsDivision of Clinical Psychology and Psychotherapy, Philipps Universität Marburg, Marburg, Germany.
Sabine RiemerDivision of Clinical Psychology and Psychotherapy, Philipps Universität Marburg, Marburg, Germany.
Verena SelberdingerDepartment of Psychiatry, Ludwig-Maximilian Universität, Munich, Germany.
Theresa StapfDepartment of Psychiatry, Ludwig-Maximilian Universität, Munich, Germany.
Frank EuteneuerDivision of Clinical Psychology and Psychotherapy, Philipps Universität Marburg, Marburg, Germany.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

contextElevated concentrations of proinflammatory cytokines have been hypothesized as an important factor in the pathophysiology of depression. Depression itself is considered to be a heterogeneous disorder. Current findings suggest that "cognitive" and "somatic" symptom dimensions are related to immune function in different ways. So far, little research has been done on the longitudinal aspects of inflammation in patients with major depression, especially with respect to different symptom dimensions of depression. Therefore, we investigated which aspects of depression may predict changes in tumor necrosis factor-alpha (TNF-alpha) and interleukin (IL)-6 over 4 weeks.

methodsForty-one patients with major depression diagnosed according to the Diagnostic and Statistical Manual of Mental Disorders, fourth edition (DSM-IV), and 45 healthy controls were enrolled. Serum measurements of TNF-alpha and IL-6 were conducted at baseline and 4 weeks later. Psychometric measures included the assessment of cognitive-affective depressive symptoms and somatic symptoms during the last 7 days as well as somatic symptoms during the last 2 years.

resultsPatients with depression showed increased levels of TNF-alpha (P<0.05) compared to healthy controls. Hierarchical regression analyses indicated that neither depressive nor somatic symptoms predict changes in proinflammatory cytokines in the whole sample of depressed patients. Moderation analyses and subsequent sex-stratified regression analyses indicated that higher somatoform symptoms during the last 2 years significantly predict an increase in TNF-alpha in women with major depression (P<0.05) but not in men. Exploratory analyses indicated that the stability of TNF-alpha and IL-6 (as indicated by intraclass correlation coefficients) over 4 weeks was high for TNF-alpha but lower for IL-6.

conclusionThe present study demonstrated that a history of somatoform symptoms may be important for predicting future changes in TNF-alpha in women with major depression.

Indexed as

interleukin-6symptom dimensiontumor necrosis factor-alpha

Identifiers

PMID25061304
PMCPMC4085300

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.